基斯脱乙酸酶6:氧化应激相关疾病和癌症的新参与者 (评论)
Fei Qu1, Qingqing Zhao1, Yi Jin2
1Department of Pathology, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250013, P.R. China.
International journal of molecular medicine
|July 11, 2025
概括
希斯脱乙酶6 (HDAC6) 通过脱乙非希斯蛋白来调节细胞的氧化应激反应. 准HDAC6显示了神经退行,癌症和心血管疾病等疾病的治疗潜力.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 海斯脱乙酶6 (HDAC6) 是细胞对氧化应激反应的关键调节剂.
- 与其他基因组脱乙酶不同,HDAC6向非基因组蛋白,影响细胞功能.
- 氧化压力与许多疾病有关,包括神经退行,癌症和心血管疾病.
研究的目的:
- 审查目前关于HDAC6在氧化应激通路中的作用的研究.
- 探索HDAC6对氧化压力相关疾病的病原发生的影响.
- 讨论针对HDAC6.6的治疗潜力.
主要方法:
- 关于HDAC6和氧化应激的最新研究的文献综述.
- 对HDAC6抑制剂的临床前试验数据的分析.
- 在疾病模型中对HDAC6的功能信息的综合.
主要成果:
- HDAC6显著影响细胞对氧化应激反应.
- 在神经退行,癌症和心血管疾病的发展中,HDAC6起着至关重要的作用.
- 临床前研究表明,HDAC6抑制剂可以改善疾病症状和进展.
结论:
- HDAC6是氧化压力相关疾病的多方面的治疗标.
- 准HDAC6为新的治疗策略提供了有希望的途径.
- 对HDAC6机制的进一步研究可能会导致各种疾病的创新疗法.
相关概念视频
Spreading of Chromatin Modifications
8.5K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.5K
Histone Modification
14.1K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
14.1K
Histone Variants at the Centromere
4.5K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.5K
Electron Transport Chain: Complex I and II
15.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.1K
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K


